Else Kröner Fresenius Prize for Medical Research

from Wikipedia, the free encyclopedia

The Else Kröner Fresenius Prize for Medical Research is a research award from the Else Kröner Fresenius Foundation for medical research. Until 2017 it was endowed with four million euros, making it one of the world's most highly endowed medical prizes. From 2020, the award is to take place every two years. The prize is now endowed with 2.5 million euros.

The winner is determined by an international jury of scientists, chaired in 2017 by the British psychiatrist Peter McGuffin . A promising research field is selected for each award.

The prize is named after the entrepreneur Else Kröner from the Fresenius company , who bequeathed her assets to the foundation named after her. In 2008 it was one of the largest foundations in Germany with foundation assets of 2.6 billion euros.

The prize was first awarded in 2013 and presented by Federal Research Minister Johanna Wanka . The 2017 award was presented, among others, by Ernst-Ludwig Winnacker , the former President of the German Research Foundation (DFG). The awarding of the 2020 award has been postponed to 2021 due to the COVID-19 pandemic .

Award winners

  • 2013 Ruslan Medzhitov for Immunobiology
  • 2017 Karl Deisseroth for research on the biological basis of mental illnesses (optogenetics, hydrogel tissue chemistry, neural circuits in depression)
  • 2020 Alessandro Aiuti for his work in the field of genome editing and gene therapy

Web links

Individual evidence

  1. ↑ Call for applications Else Kröner Fresenius Prize for Medical Research 2020. Accessed on February 21, 2019 .